Jefferies Cuts Price Target on Immunomedics (IMMU) as Clivatuzumab Program is Discontinued
Go back to Jefferies Cuts Price Target on Immunomedics (IMMU) as Clivatuzumab Program is Discontinued| Immunomedics, Inc. (NASDAQ: IMMU) | Delayed: 87.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.86 | 52 Week High | $5.44 | |||
| Open | $238.99 | 52 Week Low | $1.61 | |||
| Day High | $87.86 | P/E | N/A | |||
| Day Low | $87.86 | EPS | $-0.15 | |||
| Volume | 300,340 | |||||
